Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
about
Infection prevention and the medical director: uncharted territoryFluad®-MF59®-Adjuvanted Influenza Vaccine in Older AdultsB cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationComparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly.A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.Aging exacerbates damage and delays repair of alveolar epithelia following influenza viral pneumonia.Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.Aging Successfully: a Research and Public Health Priority for the 21(st) Century.Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review.Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.The gut microbiota in young and middle-aged rats showed different responses to chicken protein in their diet.Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United StatesThe confounded effects of age and exposure history in response to influenza vaccinationTraditional and new influenza vaccinesImmunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approachEnhanced Viral Replication by Cellular Replicative Senescence.Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cellsGenotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen.The new normal: immunomodulatory agents against sepsis immune suppression.Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza.Factors affecting immune responses to the influenza vaccine.High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection.Potential Immunotherapeutics for Immunosuppression in Sepsis.Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock.Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16.Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering.Aged Mice are More Resistant to Influenza Virus Infection due to Reduced Inflammation and Lung Pathology.
P2860
Q26825010-F37E4535-8F1F-437E-A36B-719C0C4BA92BQ27009478-BA9433A8-89EC-40AE-BD22-FA4F1E523036Q30429248-B1E237A2-E441-412B-B6F6-0109E5B59F0CQ33899392-0A351AF7-1AF9-478E-A640-75ABD761140EQ33931916-16B64397-5416-4108-8784-36C7B2FC23C6Q34306034-2524B488-A5BE-4826-85A0-32DA689AC0E5Q34993133-D726C278-5FB4-4791-AB83-2524D3B412B9Q35225020-6E9446C5-1C69-44F1-9A84-9BA0704DFD60Q35874094-1B1C9EB5-EDD0-4691-80E3-E1FA7E3106BAQ35887679-338A31E5-ADEA-4355-9507-0DA842CA0B45Q36139178-9CDA25DF-26AF-4B73-AFFC-D17A1236AB62Q36204106-CB5874D2-355C-44FF-B6FF-668DA736C1DEQ36256314-0D00963B-F2D9-4C7E-AC96-BC293855FB57Q36495566-E3DE4829-BE3D-4B32-85A5-A6D13688BC06Q36495901-98688648-9FFF-4722-BCA2-4A6008DE66BBQ37035833-0A90F86B-285D-48C4-8974-C3BA3151784CQ37233354-21DC5661-4D6D-446F-BD36-B77D279AC6B6Q37378491-9AADBCED-315F-4C9C-8769-D934DEA2D6C9Q37392506-9B7AEC6B-2A41-4D2C-8A10-C67F2BE87E3EQ37546555-A3283911-7462-4063-91AD-92CBA7B29829Q37679085-E86D69EE-50DE-4669-BCFB-04DEE12BBB24Q37686624-02E028D7-34EA-4A56-B87B-D5C52BD3FDCAQ38774410-F9094876-455A-4344-B234-0E5E135153C6Q39375320-1CDBFD26-6208-4BBB-B06F-C477BF175F05Q41244491-96EDECBE-AEC8-4943-9A6F-CC6A0884858CQ44174979-F8CEFC8B-E678-4BE2-A502-7DAB80EE891CQ47102338-1FA0F59F-BC18-4025-ADB5-14AE65561224Q47153305-3243381A-BA0A-438C-AFE0-B25BF1116AAFQ47552950-CD04D6B6-FCDB-44F6-834B-C1E4F3A34777Q47563152-9446D6DE-8C3C-468A-A458-229C8111F7CDQ55381189-24D7E314-CBC6-47F6-9830-AFD4AD3A50EE
P2860
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
@ast
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
@en
type
label
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
@ast
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
@en
prefLabel
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
@ast
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
@en
P2093
P2860
P1433
P1476
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population
@en
P2093
Adrian J Reber
David K Shay
Jin Hyang Kim
Renata Biber
Suryaprakash Sambhara
Tatiana Chirkova
Weiping Cao
P2860
P577
2011-09-30T00:00:00Z